EUVIMEDEUVIMED entdecken
Open Access

4‐Phenylbutyrate promoted wild‐type γ‐aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2 +/Q390X mice associated with Dravet syndrome

Wangzhen Shen, Carson Flamm, Aiden J Delahanty, Emmett Casteel, Marshall Biven, Melissa B DeLeeuw, Sarah Poliquin, Gerald Nwosu, Karishma Randhave, Jing-Qiong Kang iD

Epilepsia · 2024-01 · 65 (1) · 204-217

DOI: 10.1111/epi.17779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 29.11.2023. Verfasst von Wangzhen Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic, Epilepsy, Phenylbutyrates. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NINDS NIH HHS, Citizens United for Research in Epilepsy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective γ‐Aminobutyric acid type A (GABA A ) receptor subunit gene mutations are major causes of various epilepsy syndromes, including severe kinds such as Dravet syndrome. Although the GABA A receptor is a major target for antiseizure medications, treating GABA A receptor mutations with receptor channel modulators is ineffective. Here, we determined the effect of a novel treatment with 4‐phenylbutyrate (PBA) in Gabrg2 +/Q390X knockin mice associated with Dravet syndrome.

Methods

We used biochemistry in conjunction with differential tagging of the wild‐type and the mutant alleles, live brain slice surface biotinylation, microsome isolation, patch‐clamp whole‐cell recordings, and video‐monitoring synchronized electroencephalographic (EEG) recordings in Gabrg2 +/Q390X mice to determine the effect of PBA in vitro with recombinant GABA A receptors and in vivo with knockin mice.

Results

We found that PBA reduced the mutant γ2(Q390X) subunit protein aggregates, enhanced the wild‐type GABA A receptor subunits' trafficking, and increased the membrane expression of the wild‐type receptors. PBA increased the current amplitude of GABA‐evoked current in human embryonic kidney 293T cells and the neurons bearing the γ2(Q390X) subunit protein. PBA also proved to reduce endoplasmic reticulum (ER) stress caused by the mutant γ2(Q390X) subunit protein, as well as mitigating seizures and EEG abnormalities in the Gabrg2 +/Q390X mice. Significance This research has unveiled a promising and innovative approach for treating epilepsy linked to GABA A receptor mutations through an unconventional antiseizure mechanism. Rather than directly modulating the affected mutant channel, PBA facilitates the folding and transportation of wild‐type receptor subunits to the cell membrane and synapse. Combining these findings with our previous study, which demonstrated PBA's efficacy in restoring GABA transporter 1 (encoded by SLC6A1 ) function, we propose that PBA holds significant potential for a wide range of genetic epilepsies. Its ability to target shared molecular pathways involving mutant protein ER retention and impaired protein membrane trafficking suggests broad application in treating such conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicEpilepsyPhenylbutyratesMiceHumansAnimalsReceptors, GABA-AReceptors, GABASeizuresgamma-Aminobutyric AcidEndoplasmic Reticulum Stress

Stichwörter der Autor:innen

4-phenylbutyrateER stressGABAA receptorsGabrg2+/Q390X knockin miceepilepsy

Substanzen

Receptors, GABA-AReceptors, GABA4-phenylbutyric acidgamma-Aminobutyric AcidGabrg2 protein, mousePhenylbutyrates

Autor:innen und Institutionen

  • Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, Tennessee, USA.
  • Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Jing-Qiong Kang

Förderung

  • NICHD NIH HHS
  • NINDS NIH HHS
  • Citizens United for Research in Epilepsy
  • Dravet Syndrome Foundation
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Shen, W., Flamm, C., Delahanty, A. J., Casteel, E., Biven, M., DeLeeuw, M. B., Poliquin, S., Nwosu, G., Randhave, K., & Kang, J. Q. (2024). 4‐Phenylbutyrate promoted wild‐type γ‐aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2 +/Q390X mice associated with Dravet syndrome. Epilepsia, 65(1), 204-217. https://doi.org/10.1111/epi.17779

Vancouver

Shen W, Flamm C, Delahanty AJ, Casteel E, Biven M, DeLeeuw MB, et al. 4‐Phenylbutyrate promoted wild‐type γ‐aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2 +/Q390X mice associated with Dravet syndrome. Epilepsia. 2024;65(1):204-217. doi:10.1111/epi.17779

BibTeX
@article{Shen2024,
  author = {Shen, Wangzhen and Flamm, Carson and Delahanty, Aiden J and Casteel, Emmett and Biven, Marshall and DeLeeuw, Melissa B and Poliquin, Sarah and Nwosu, Gerald and Randhave, Karishma and Kang, Jing-Qiong},
  title = {4‐Phenylbutyrate promoted wild‐type γ‐aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2 +/Q390X mice associated with Dravet syndrome},
  journal = {Epilepsia},
  year = {2024},
  volume = {65},
  number = {1},
  pages = {204--217},
  doi = {10.1111/epi.17779}
}
Kostenlos starten →